Detalhe da pesquisa
1.
Alsinol, an arylamino alcohol derivative active against Plasmodium, Babesia, Trypanosoma, and Leishmania: past and new outcomes.
Parasitol Res
; 119(10): 3503-3515, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32772176
2.
Primaquine-quinoxaline 1,4-di-N-oxide hybrids with action on the exo-erythrocytic forms of Plasmodium induce their effect by the production of reactive oxygen species.
Malar J
; 18(1): 201, 2019 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31217011
3.
Pediatric asthma treatment: What to do when international guideline recommendations do not agree.
Ann Allergy Asthma Immunol
; 121(1): 7-13.e4, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551403
4.
New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmodial and antileishmanial activity.
Bioorg Med Chem Lett
; 27(8): 1820-1825, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28291694
5.
Synthesis, biological evaluation and structure-activity relationships of new quinoxaline derivatives as anti-Plasmodium falciparum agents.
Molecules
; 19(2): 2166-80, 2014 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24552985
6.
New amide derivatives of quinoxaline 1,4-di-N-oxide with leishmanicidal and antiplasmodial activities.
Molecules
; 18(4): 4718-27, 2013 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23609622
7.
The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine.
Mem Inst Oswaldo Cruz
; 107(6): 820-3, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22990975
8.
New quinoxaline derivatives as potential MT1 and MT2 receptor ligands.
Molecules
; 17(7): 7737-57, 2012 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22732886
9.
Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives.
Molecules
; 17(8): 9451-61, 2012 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22871647
10.
New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
Bioorg Med Chem Lett
; 21(12): 3699-703, 2011 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21570839
11.
New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities.
Bioorg Med Chem Lett
; 21(15): 4498-502, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21724395
12.
Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships.
Exp Parasitol
; 128(2): 97-103, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354139
13.
Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives.
Exp Parasitol
; 127(4): 745-51, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21272583
14.
Studies on log Po/w of quinoxaline di-N-oxides: a comparison of RP-HPLC experimental and predictive approaches.
Molecules
; 16(9): 7893-908, 2011 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22143549
15.
New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.
Bioorg Med Chem
; 18(7): 2713-9, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20233660
16.
Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents.
Bioorg Med Chem
; 18(21): 7365-79, 2010 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20932767
17.
Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
Bioorg Med Chem
; 17(1): 385-9, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19058970
18.
Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
Bioorg Med Chem
; 17(2): 641-52, 2009 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19110434
19.
New 1-aryl-3-substituted propanol derivatives as antimalarial agents.
Molecules
; 14(10): 4120-35, 2009 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19924051
20.
Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
Molecules
; 14(6): 2256-72, 2009 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19553897